Details for New Drug Application (NDA): 020696
✉ Email this page to a colleague
The generic ingredient in ANTIZOL is fomepizole. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fomepizole profile page.
Summary for 020696
Tradename: | ANTIZOL |
Applicant: | Par Pharm Inc |
Ingredient: | fomepizole |
Patents: | 1 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 4, 1997 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 30, 2027 | Product Flag? | Y | Substance Flag? | Y | Delist Request? |
Complete Access Available with Subscription